Taken together, our study demonstrates that miR-429/200a/b and miR-141/200c clusters are identified as potential biomarkers for NEC through regulation of VEGFA, SELE, KDR, FLT1, and HGF, which yields a better understanding for NEC treatment. The gene discussed is SELE; the disease is necrotizing enterocolitis.